Molecular Diagnostics


EKF Diagnostics Showcases STAT-Site WB β-ketone and Glucose Handheld Analyzer Live & in Person at MEDICA 2021
EKF Diagnostics (Cardiff, Wales, UK) showcased its recently launched STAT-Site WB β-ketone and glucose handheld analyzer at this year’s MEDICA, the world's largest medical trade fair for medical technology, electromedical equipment, laboratory equipment, diagnostics and pharmaceuticals.. More...15 Nov 2021

Precise Diagnosis of Mitochondrial Diseases Using Whole Genome Sequencing
A team of British researchers has demonstrated that a whole genome sequencing approach could identify patients with difficult to diagnose mitochondrial diseases and distinguish them from non-mitochondrial disorders. More...15 Nov 2021

Biovendor Group presents its CLIA, NGS, Microblot Array, microRNA and LAMP Product Lines at MEDICA 2021
BioVendor Group (Brno, Czech Republic) presented its CLIA, NGS, Microblot Array, microRNA and LAMP product lines at the 2021 edition of MEDICA, the world's largest trade fair for medical technology, held from 15 to 18 November in Düsseldorf, Germany. More...15 Nov 2021

Vircell Showcases Its Powerful Automation System and Immunoassay Testing Kits at MEDICA 2021
Vircell (Granada, Spain) exhibited its powerful automation system and immunoassay testing kits at this year's MEDICA, the world's largest annual medical technology trade fair, which took place from 15-18 November in Düsseldorf, Germany. More...15 Nov 2021


Genome-Wide cfDNA Analysis Detects Therapy Response in B-Cell Lymphoma
Diffuse large B-cell lymphoma (DLBCL) is the most common, aggressive type of non-Hodgkin lymphoma. Although 50% to 60% of individuals achieve cure with chemoimmunotherapy, outcomes are poor for relapsed/refractory disease. More...10 Nov 2021
In Other News
Endotoxemia Genetic Profile Reveals an Association with Thromboembolism and Stroke
Inflammatory Cytokine Levels Predict Patient Outcomes After Traumatic Injury
New Biomarker Improves Definition of Medulloblastoma Risk
Seegene Launches STARlet-AIOS All-in-One System that Fulfills Critical Need for Fully Automated, High-Throughput Real-Time PCR Testing
Sibling Cascade Testing More Cost Effective in Pediatric Cancer
A Liquid Biopsy Approach for Predicting Likely Relapse Following Treatment of Medulloblastoma in Children
Gene Expression Test Improves Idiopathic Pulmonary Fibrosis Diagnosis
Cyclic Adenosine Monophosphate (cAMP) May Be a Diagnostic Biomarker for Chronic Respiratory Diseases
Bio-Rad Launches New CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics
New Method Promises Rapid Isolation of Biomarker-Rich Extracellular Vesicles
AI-Based Technology Identifies Genetic Causes of Serious Diseases
Meridian Launches Innovative Air-Dryable qPCR Mixes Enabling Direct Detection of DNA or RNA from Urine Samples
Next Generation Sequencing (NGS)-Based Breast Cancer Monitoring Test Could Aid Timely Treatment Decisions
Blood Test Combines Cutting-Edge Genomics and AI to Identify Persistent or Recurrent Cancer
Revolution in Rapid Testing: A New Generation of Programmable Lateral Flow Assays
Non-Invasive Nasal Swab Test Leverages Advanced Genomic Technology to Detect Lung Cancer Risk
Low Anti-SARS-CoV-2 S Antibody Levels Predict Increased Mortality
Biohit’s Innovative GastroPanel Quick Test Receives CE Mark
Fecal Immunochemical Tubes Sourced to Analyze Gut Microbiome for CRC
First-of-Its-Kind Testing Device Allows For Rapid Detection of Bacteria That Identify Risk for Preterm Birth
Mutation Analysis Links Angioimmunoblastic T-Cell Lymphoma to Clonal Hematopoiesis
Unique Gene Detects Mycobacterium Tuberculosis in Clinical Sputum
Whole-Genome Sequencing Applied to Acutely Ill Infants
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.